Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Vascular Control Systems, Inc. — Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

46 daysmedian FDA review time
246 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K060573BURBANK TENACULUMVascular Control Systems, Inc.2006-04-21460
K052209VCS DOPPLER TRANSCEIVER, MODEL 09-0023-01Vascular Control Systems, Inc.2005-09-06220
K032125CSTAT, MODELS 09-0014-01 AND 09-0014-02Vascular Control Systems, Inc.2004-02-092140
K031812TRANSVAGINAL DOPPLER CLAMP, MODELS: 09-0016-01, 09-0016-02, Vascular Control Systems, Inc.2003-12-121830
K031358TRANSVAGINAL DOPPLER PROBEVascular Control Systems, Inc.2003-05-0990
K030078BURBANK TENACULUM, MODEL 09-0011-01Vascular Control Systems, Inc.2003-01-24150
K023154VCS-A SERIES CLAMP WITH DOPPLER ULTRASOUND, MODEL 09-0007-01Vascular Control Systems, Inc.2002-12-20880
K023024TRANSVAGINAL DOPPLER PROBE, MODEL 09-0006-02Vascular Control Systems, Inc.2002-09-26150
K011863VCS-A SERIES CLAMPVascular Control Systems, Inc.2002-02-152460

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda